Clear Labs
Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs democratizes genomics applications to deliver increased clarity. Clear Labs' turnkey platform accelerates outcomes and improves accuracy - from foodborne pathogens to infectious diseases, including SARS-CoV-2. With a novel approach, Clear Labs is helping the world better understand, track and mitigate tomorrow's novel pathogens.
Last updated on
About Clear Labs
Founded
2014Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$126MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
San CarlosState
CaliforniaCountry
United StatesClear Labs
Find your buyer within Clear Labs